Suppr超能文献

复发性脑膜瘤的切除程度和Ki-67标记指数

Degree of Resection and Ki-67 Labeling Index for Recurring Meningiomas.

作者信息

Menger Richard, Connor David E, Chan Alvin Y, Jain Gary, Nanda Anil

机构信息

Department of Neurosurgery, LSU Health Sciences Center Shreveport.

Medical College of Wisconsin.

出版信息

Cureus. 2017 Nov 3;9(11):e1820. doi: 10.7759/cureus.1820.

Abstract

Objective Meningioma recurrence after resection is likely influenced by multiple surgical and histologic factors. In this study, the degree of resection and tumor immunoreactivity to MIB-1 (i.e., Ki-67 labeling index (LI)) are described in recurrent and non-recurrent meningioma cases. Methods Data regarding tumor location, the degree of resection, histologic features, and the degree of Ki-67 positivity were collected for 32 patients treated between September 2008 and July 2009. Follow-up for recurrence was assessed through five years. Results A total of 32 patients (13 males; 19 females) underwent resection. The mean age was 53.3 years. Gross total resection (GTR) occurred in 25 (78.1%) cases. Near-total resection (NTR) occurred in five (15.6%) cases. Subtotal resection (STR) occurred in two (6.2%) cases. The overall mean Ki-67 LI score was 9.75% (ranging between 1% to 48%). The mean Ki-67 LI for GTR, NTR, and STR cases were 8.0%, 10.2%, and 29.5% respectively. Tumor recurrence occurred in five (15.6%) patients. The mean Ki-67 LI for recurrence lesions was 22.2%. Conclusion We present our descriptive data for Ki-67 LI for initial tumors and recurrence. The risk of recurrence following resection of meningiomas may be associated with the degree of Ki-67 positivity.

摘要

目的 脑膜瘤切除术后复发可能受多种手术及组织学因素影响。本研究描述了复发性和非复发性脑膜瘤病例的切除程度及肿瘤对MIB - 1的免疫反应性(即Ki - 67标记指数(LI))。方法 收集了2008年9月至2009年7月间接受治疗的32例患者的肿瘤位置、切除程度、组织学特征及Ki - 67阳性程度的数据。通过五年时间评估复发情况。结果 共有32例患者(13例男性;19例女性)接受了切除手术。平均年龄为53.3岁。25例(78.1%)实现了全切(GTR)。5例(15.6%)为近全切(NTR)。2例(6.2%)为次全切(STR)。总体平均Ki - 67 LI评分为9.75%(范围在1%至48%之间)。GTR、NTR和STR病例的平均Ki - 67 LI分别为8.0%、10.2%和29.5%。5例(15.6%)患者出现肿瘤复发。复发灶的平均Ki - 67 LI为22.2%。结论 我们展示了初始肿瘤及复发肿瘤的Ki - 67 LI描述性数据。脑膜瘤切除术后的复发风险可能与Ki - 67阳性程度有关。

相似文献

2
The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.脑膜瘤中的Ki-67增殖抗原。600例病例的经验。
Acta Neurochir (Wien). 2004 Jan;146(1):37-44; discussion 44. doi: 10.1007/s00701-003-0173-4. Epub 2003 Dec 22.
6
Skull base atypical meningioma: long term surgical outcome and prognostic factors.颅底非典型脑膜瘤:长期手术结果及预后因素
Clin Neurol Neurosurg. 2015 Jan;128:112-6. doi: 10.1016/j.clineuro.2014.11.009. Epub 2014 Nov 24.

本文引用的文献

6
The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.脑膜瘤中的Ki-67增殖抗原。600例病例的经验。
Acta Neurochir (Wien). 2004 Jan;146(1):37-44; discussion 44. doi: 10.1007/s00701-003-0173-4. Epub 2003 Dec 22.
7
The recurrence of intracranial meningiomas after surgical treatment.手术治疗后颅内脑膜瘤的复发
J Neurol Neurosurg Psychiatry. 1957 Feb;20(1):22-39. doi: 10.1136/jnnp.20.1.22.
8
TP53 mutations in human meningiomas.人类脑膜瘤中的TP53突变
Int J Biol Markers. 2002 Jan-Mar;17(1):42-8. doi: 10.5301/jbm.2008.3174.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验